home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Pharmacovigilance and Risk Management 2011

 
  October 09, 2010  
     
 
Renaissance Washington, DC Hotel , Washington, DC
Jan 9 2011 8:00AM - Jan 12 2011 5:00PM


PRECONFERENCE WORKSHOPS
Several preconference workshops are being developed and will be offered on January 9, 2011. Monitor
www.diahome.org for information as it becomes available.

Conference Overview

Clinical trial safety and postmarketing pharmacovigilance is more critical than ever in the development and evaluation of the safe use of marketed medical products. This comprehensive three-day program will discuss the current complexities and controversies in pharmacovigilance and risk management throughout all phases of development and marketed use, how to optimally utilize epidemiological, clinical pharmacological and other techniques, risk management strategies, and how to create an effective organizational “system.” This program will focus primarily on drug products and biologics, but medical devices will have a limited role in the discussions.

Event Code:
11002

TABLETOP EXHIBIT INFORMATION
Attendees may visit the tabletop exhibits during the event and receptions.
For further information, contact Jeff Korn, Exhibits Associate,
Phone +1.215.442.6184 / Fax +1.215.442.6199, email Jeff.Korn@diahome.org

 
 
Organized by: DIA
Invited Speakers: Call contact
 
Deadline for Abstracts: Call contact
 
Registration: Contact Rachel Minnick, Program Developer, Phone +1.215.442.6131
Fax +1.215.442.6199
E-mail: rachel.minnick@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.